IgE-话题@MedSci - williamhill asia

#IgE#

86篇内容 | 2048人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2213964, encodeId=5176221396497, content=<a href='/topic/show?id=c0ae9405422' target=_blank style='color:#2F92EE;'>#过敏性鼻炎#</a> <a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a> <a href='/topic/show?id=728c65040e' target=_blank style='color:#2F92EE;'>#ECP#</a>, objectTitle=J Asthma Allergy：过敏性鼻炎患者和非过敏性鼻炎患者的血液、生化和血清过敏介质水平, objectType=article, longId=833687, objectId=a32d83368e83, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240708/1720429240984_1935437.jpg, objectUrl=/article/show_article.do?id=a32d83368e83, replyNumber=0, likeNumber=0, createdTime=2024-07-08, rootId=0, userName=williamhill asia 管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a32d83368e83, moduleTitle=J Asthma Allergy：过敏性鼻炎患者和非过敏性鼻炎患者的血液、生化和血清过敏介质水平, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=a32d83368e83)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1426407, encodeId=1136142640ea3, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Clin Epigenetics：非裔美国人胰岛素抵抗的表观基因组关联研究, objectType=article, longId=733161, objectId=d14ae33161f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d14ae33161f3, replyNumber=0, likeNumber=49, createdTime=2022-07-26, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d14ae33161f3, moduleTitle=Clin Epigenetics：非裔美国人胰岛素抵抗的表观基因组关联研究, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=d14ae33161f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426406, encodeId=01751426406bd, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=诺华的ligelizumab在自发性荨麻疹研究中未能击败Xolair, objectType=article, longId=292585, objectId=104d2925856a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=104d2925856a, replyNumber=0, likeNumber=58, createdTime=2021-12-24, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=104d2925856a, moduleTitle=诺华的ligelizumab在自发性荨麻疹研究中未能击败Xolair, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=104d2925856a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426405, encodeId=2831142640520, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=J Allergy Clin Immunol：IgE对鼻息肉有影响么？, objectType=article, longId=210054, objectId=21b32100540a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21b32100540a, replyNumber=0, likeNumber=0, createdTime=2021-04-17, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21b32100540a, moduleTitle=J Allergy Clin Immunol：IgE对鼻息肉有影响么？, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=21b32100540a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426404, encodeId=7e7e1426404bc, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Clin Epigenetics :精子中的生物标记物可能与后代自闭症相关, objectType=article, longId=206047, objectId=694e20604e6c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=694e20604e6c, replyNumber=0, likeNumber=65, createdTime=2021-01-24, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=694e20604e6c, moduleTitle=Clin Epigenetics :精子中的生物标记物可能与后代自闭症相关, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=694e20604e6c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426403, encodeId=ac6c142640373, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=慢性自发性荨麻疹(CSU)新药！诺华新一代IgE抗体ligelizumab获美国FDA突破性药物资格!, objectType=article, longId=205804, objectId=2e6320580469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6320580469, replyNumber=0, likeNumber=66, createdTime=2021-01-18, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6320580469, moduleTitle=慢性自发性荨麻疹(CSU)新药！诺华新一代IgE抗体ligelizumab获美国FDA突破性药物资格!, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=2e6320580469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426402, encodeId=5d9614264021e, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=World Allergy Organ J：鼻对Der p的特异性IgE筛选测试不能预测非过敏性鼻炎患者鼻腔挑战试验结果 , objectType=article, longId=202312, objectId=3ae620231255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ae620231255, replyNumber=0, likeNumber=65, createdTime=2020-10-22, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ae620231255, moduleTitle=World Allergy Organ J：鼻对Der p的特异性IgE筛选测试不能预测非过敏性鼻炎患者鼻腔挑战试验结果 , moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=3ae620231255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426401, encodeId=34e51426401ed, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=JNNP：苍白球深部脑电刺激治疗原发性Meige综合征：临床结果和精神特征, objectType=article, longId=202047, objectId=cd0f20204ed4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd0f20204ed4, replyNumber=0, likeNumber=67, createdTime=2020-10-14, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd0f20204ed4, moduleTitle=JNNP：苍白球深部脑电刺激治疗原发性Meige综合征：临床结果和精神特征, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=cd0f20204ed4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426400, encodeId=7eb4142640093, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Clin Epigenetics：口服维生素C可恢复血液恶性肿瘤患者的血浆维生素C的水平, objectType=article, longId=201696, objectId=e0c8201696b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0c8201696b5, replyNumber=0, likeNumber=64, createdTime=2020-10-06, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0c8201696b5, moduleTitle=Clin Epigenetics：口服维生素C可恢复血液恶性肿瘤患者的血浆维生素C的水平, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e0c8201696b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426399, encodeId=c97c142639938, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Epigenetics：组蛋白赖氨酸脱甲基酶KDM7A是胚胎正常发育所必需的, objectType=article, longId=201557, objectId=92d820155ee0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92d820155ee0, replyNumber=0, likeNumber=61, createdTime=2020-10-04, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92d820155ee0, moduleTitle=Epigenetics：组蛋白赖氨酸脱甲基酶KDM7A是胚胎正常发育所必需的, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=92d820155ee0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426398, encodeId=9a8314263988e, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Ampligen或可预防COVID-19，体外模型证明Ampligen将SARS-CoV-2病毒载量降低90％, objectType=article, longId=200064, objectId=d39420006480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d39420006480, replyNumber=0, likeNumber=62, createdTime=2020-09-01, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d39420006480, moduleTitle=Ampligen或可预防COVID-19，体外模型证明Ampligen将SARS-CoV-2病毒载量降低90％, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=d39420006480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426397, encodeId=6dea142639ef1, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=奥马珠单抗在欧洲获批，成为治疗严重慢性鼻-鼻窦炎的**IgE单抗, objectType=article, longId=198981, objectId=4363198981ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4363198981ee, replyNumber=0, likeNumber=70, createdTime=2020-08-09, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4363198981ee, moduleTitle=奥马珠单抗在欧洲获批，成为治疗严重慢性鼻-鼻窦炎的**IgE单抗, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4363198981ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426396, encodeId=1dc2142639693, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Nature Machine Intelligence：深度学习实现前列腺癌病理的高准度分析 , objectType=article, longId=198557, objectId=3dd519855e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd519855e43, replyNumber=0, likeNumber=60, createdTime=2020-08-03, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd519855e43, moduleTitle=Nature Machine Intelligence：深度学习实现前列腺癌病理的高准度分析 , moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=3dd519855e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426395, encodeId=f3b21426395e4, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Humanigen的抗GM-CSF单抗Lenzilumab正在进行临床试验，评估是否可用于预防新冠病毒感染引起的细胞因子风暴, objectType=article, longId=189675, objectId=c8cd1896e5a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8cd1896e5a4, replyNumber=0, likeNumber=65, createdTime=2020-03-12, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8cd1896e5a4, moduleTitle=Humanigen的抗GM-CSF单抗Lenzilumab正在进行临床试验，评估是否可用于预防新冠病毒感染引起的细胞因子风暴, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c8cd1896e5a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426394, encodeId=2b551426394ca, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=欧洲药品管理局CHMP推荐了抗耐药菌药物Fetcroja和抗感染药物Tigecycline上市, objectType=article, longId=189500, objectId=7a3e18950020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a3e18950020, replyNumber=0, likeNumber=64, createdTime=2020-03-08, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a3e18950020, moduleTitle=欧洲药品管理局CHMP推荐了抗耐药菌药物Fetcroja和抗感染药物Tigecycline上市, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=7a3e18950020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426393, encodeId=6c87142639384, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Epigenomics：人类脂肪干细胞成骨分化过程中的环状RNA差异表达谱, objectType=article, longId=188106, objectId=10f718810639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10f718810639, replyNumber=0, likeNumber=58, createdTime=2020-02-16, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10f718810639, moduleTitle=Epigenomics：人类脂肪干细胞成骨分化过程中的环状RNA差异表达谱, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=10f718810639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426392, encodeId=8860142639231, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=NEJM的：诺华的IgE单抗Ligelizumab在慢性自发性荨麻疹的III期临床中完胜奥马珠单抗, objectType=article, longId=186027, objectId=868418602e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868418602e8e, replyNumber=0, likeNumber=0, createdTime=2020-01-11, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868418602e8e, moduleTitle=NEJM的：诺华的IgE单抗Ligelizumab在慢性自发性荨麻疹的III期临床中完胜奥马珠单抗, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=868418602e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426391, encodeId=ffbc142639134, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=FDA授予Precigen公司的非病毒多基因CAR-T疗法PRGN-3006孤儿药指定，用于治疗急性髓细胞性白血病, objectType=article, longId=185922, objectId=f2591859220a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2591859220a, replyNumber=0, likeNumber=65, createdTime=2020-01-10, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2591859220a, moduleTitle=FDA授予Precigen公司的非病毒多基因CAR-T疗法PRGN-3006孤儿药指定，用于治疗急性髓细胞性白血病, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f2591859220a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426390, encodeId=f36b142639061, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=2019 AIGO/SIED/SIGE/SIMI 意见书：慢性萎缩性胃炎的自然病史，诊断和治疗管理, objectType=article, longId=182404, objectId=266618240468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=266618240468, replyNumber=0, likeNumber=47, createdTime=2019-11-06, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=266618240468, moduleTitle=2019 AIGO/SIED/SIGE/SIMI 意见书：慢性萎缩性胃炎的自然病史，诊断和治疗管理, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=266618240468)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426389, encodeId=c7f114263892c, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=安进将以27亿美元收购百济神州（BeiGene），扩大其在中国癌症市场的占有率, objectType=article, longId=182338, objectId=c2371823384b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2371823384b, replyNumber=0, likeNumber=82, createdTime=2019-11-05, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2371823384b, moduleTitle=安进将以27亿美元收购百济神州（BeiGene），扩大其在中国癌症市场的占有率, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c2371823384b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

IgE

2020-05-29

williamhill asia 管理员 (审核中...)

前往app查看评论内容

#过敏性鼻炎# #IgE# #ECP#

J Asthma Allergy：过敏性鼻炎患者和非过敏性鼻炎患者的血液、生化和血清过敏介质水平

2024-07-08发表于上海

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Clin Epigenetics：非裔美国人胰岛素抵抗的表观基因组关联研究

2022-07-26

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

诺华的ligelizumab在自发性荨麻疹研究中未能击败Xolair

2021-12-24

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

J Allergy Clin Immunol：IgE对鼻息肉有影响么？

2021-04-17

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Clin Epigenetics :精子中的生物标记物可能与后代自闭症相关

2021-01-24

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

慢性自发性荨麻疹(CSU)新药！诺华新一代IgE抗体ligelizumab获美国FDA突破性药物资格!

2021-01-18

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

World Allergy Organ J：鼻对Der p的特异性IgE筛选测试不能预测非过敏性鼻炎患者鼻腔挑战试验结果

2020-10-22

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

JNNP：苍白球深部脑电刺激治疗原发性Meige综合征：临床结果和精神特征

2020-10-14

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Clin Epigenetics：口服维生素C可恢复血液恶性肿瘤患者的血浆维生素C的水平

2020-10-06

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Epigenetics：组蛋白赖氨酸脱甲基酶KDM7A是胚胎正常发育所必需的

2020-10-04

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Ampligen或可预防COVID-19，体外模型证明Ampligen将SARS-CoV-2病毒载量降低90％

2020-09-01

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

奥马珠单抗在欧洲获批，成为治疗严重慢性鼻-鼻窦炎的**IgE单抗

2020-08-09

智者为医08 (审核中...)

前往app查看评论内容

#IgE#

Nature Machine Intelligence：深度学习实现前列腺癌病理的高准度分析

2020-08-03

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Humanigen的抗GM-CSF单抗Lenzilumab正在进行临床试验，评估是否可用于预防新冠病毒感染引起的细胞因子风暴

2020-03-12

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

欧洲药品管理局CHMP推荐了抗耐药菌药物Fetcroja和抗感染药物Tigecycline上市

2020-03-08

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Epigenomics：人类脂肪干细胞成骨分化过程中的环状RNA差异表达谱

2020-02-16

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

NEJM的：诺华的IgE单抗Ligelizumab在慢性自发性荨麻疹的III期临床中完胜奥马珠单抗

2020-01-11

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

FDA授予Precigen公司的非病毒多基因CAR-T疗法PRGN-3006孤儿药指定，用于治疗急性髓细胞性白血病

2020-01-10

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

2019 AIGO/SIED/SIGE/SIMI 意见书：慢性萎缩性胃炎的自然病史，诊断和治疗管理

2019-11-06

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

安进将以27亿美元收购百济神州（BeiGene），扩大其在中国癌症市场的占有率

2019-11-05

科室
- - 订阅+
  - 更多科室
工具
服务